APL, one of Europe’s largest manufacturers of extemporaneous medicines and a leading contract manufacturer within the life science sector, has intensified its focus on innovation.
A New Kind of Biologics Company: Interview with CEO Dr Janet Hoogstraate
NorthX, a leading development and manufacturing organisation with focus on advanced biologics, has expanded its offering through a recent acquisition, significantly boosting its market position.